Faculty

ABSTRACT:  The field of additive manufacturing (often referred to as 3-D printing) is experiencing a period of tremendous growth.  Applications are being found and continue to emerge in numerous sectors, such as consumer products, aerospace, healthcare, automotive, and many more.  Today's talk will give a brief overview of the various additive manufacturing technologies, some industrial examples will be shared, and finally, challenges within each technology will be highlighted.

ABSTRACT:  Fine particles under 30 microns are very sticky and therefore extremely difficult to handle, due to the stronger interparticle forces, leading to poor powder flowability and fluidization.  However, they are also very useful due to their small size and the very large specific surface areas.  A nanotechnology has been developed that can significantly enhance fine particle flowability by coating a small fraction of nano particles onto their surfaces.

ABSTRACT:   IGPC Ethanol located in Southwestern Ontario is a first generation corn to ethanol plant commissioned in September 2008. Today, IGPC produces 200 million litres of ethanol and 170,000 tonnes of distiller’s grains on a yearly basis, as well as 4,000 tonnes of corn oil for biodiesel production.

ABSTRACT:  Regenerative medicine offers great hope in curing many currently untreatable diseases. Tissue engineering and stem cell therapy are the two main components of regenerative medicine. In this talk, I will discuss how engineering can make contributions to this highly interdisciplinary field, including biomaterials as 3D scaffolds, bioreactor design, and stem cell bioprocessing.

Bio-SketchProfessor Hua (Cathy) Ye, University of Oxford

ABSTRACT:   The Regenerative Medicine and Skeleton laboratory (INSERM U1229, Nantes, France) has developed an injectable and self-hardening silated-HydroxyPropylMethyl Cellulose (Si-HPMC) hydrogel. In this talk, we will go through our recent approaches using Si-HPMC hydrogels as a drug and/or cell carrier in the context of degenerative diseases. Intervertebral disc (IVD) disease is a major cause of low back pain and a low-invasive approach for intradiscal delivery of therapeutics is of particular interest.